Page last updated: 2024-10-16

curdlan and Disease Models, Animal

curdlan has been researched along with Disease Models, Animal in 13 studies

D-hexose : A hexose that has D-configuration at position 5.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"In curdlan-treated SKG mice, arthritis, enthesitis, and ileitis were IL-23 dependent."3.80Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. ( Baillet, AC; Benham, H; Brown, MA; Hasnain, SZ; Kikly, K; McGuckin, MA; Rehaume, LM; Ruutu, M; Strutton, G; Thomas, GP; Thomas, R; Tseng, HW; Velasco, J; Wang, R, 2014)
"Stat-3p inhibition is a promising treatment for both inflammation and new bone formation in AS."1.62STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis. ( Choi, SH; Choi, YD; Jin, SH; Jo, S; Kim, J; Kim, JY; Kim, MJ; Kim, TH; Kim, TJ; Lee, YJ; Park, PR; Park, YS; Shim, SC; Song, HC; Won, EJ, 2021)
"Curdlan was associated with production of the disease-resolving T-helper (Th) 1 and Th17-inducing cytokines interleukin (IL)-6, IL-1β, and IL-23, as well as with production of Th17 cytokines IL-17 and IL-22, as determined by enzyme-linked immunosorbent assay (ELISA) and real time polymerase chain reaction (RT-PCR)."1.39Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. ( Das, PK; Ghosh, K; Kar, S; Saha, A; Sharma, G; Ukil, A, 2013)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (53.85)24.3611
2020's6 (46.15)2.80

Authors

AuthorsStudies
Xie, Z1
Yu, W1
Zheng, G1
Li, J1
Cen, S1
Ye, G1
Li, Z1
Liu, W1
Li, M1
Lin, J2
Su, Z1
Che, Y1
Ye, F1
Wang, P1
Wu, Y1
Shen, H1
Min, HK1
Choi, J1
Lee, SY1
Lee, AR1
Min, BM1
Cho, ML1
Park, SH1
Sato, F1
Nakamura, Y1
Katsuki, A1
Khadka, S1
Ahmad, I1
Omura, S1
Martinez, NE1
Tsunoda, I2
Ganbold, T1
Bao, Q1
Zandan, J1
Hasi, A1
Baigude, H1
Jo, S1
Won, EJ1
Kim, MJ1
Lee, YJ1
Jin, SH1
Park, PR1
Song, HC1
Kim, J1
Choi, YD1
Kim, JY1
Shim, SC1
Choi, SH1
Park, YS1
Kim, TH1
Kim, TJ1
Gu, C1
Upchurch, K1
Horton, J1
Wiest, M1
Zurawski, S1
Millard, M1
Kane, RR1
Joo, H1
Miller, LA1
Oh, S2
Benham, H1
Rehaume, LM1
Hasnain, SZ1
Velasco, J1
Baillet, AC1
Ruutu, M1
Kikly, K1
Wang, R1
Tseng, HW1
Thomas, GP1
Brown, MA1
Strutton, G1
McGuckin, MA1
Thomas, R1
Wu, TC1
Xu, K1
Banchereau, R1
Marches, F1
Yu, CI1
Martinek, J1
Anguiano, E1
Pedroza-Gonzalez, A1
Snipes, GJ1
O'Shaughnessy, J1
Nishimura, S1
Liu, YJ1
Pascual, V1
Banchereau, J1
Palucka, K1
Lee, EJ1
Vance, EE1
Brown, BR1
Snow, PS1
Clowers, JS2
Sakaguchi, S1
Rosenzweig, HL2
Jiang, N1
Zhao, G1
Hu, L1
Che, C1
Li, C1
Wang, Q1
Xu, Q1
Peng, X1
Nunez, G1
Rosenbaum, JT1
Davey, MP1
Libbey, JE1
Fujinami, RS1
Ghosh, K1
Sharma, G1
Saha, A1
Kar, S1
Das, PK1
Ukil, A1

Other Studies

13 other studies available for curdlan and Disease Models, Animal

ArticleYear
TNF-α-mediated m
    Nature communications, 2021, 09-10, Volume: 12, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Adenosine; Animals; beta-Glucans; Biopsy; Bone Marrow; Case-Co

2021
Vitronectin-derived bioactive peptide prevents spondyloarthritis by modulating Th17/Treg imbalance in mice with curdlan-induced spondyloarthritis.
    PloS one, 2022, Volume: 17, Issue:1

    Topics: Animals; beta-Glucans; Celecoxib; Cytokines; Disease Models, Animal; Disease Progression; Female; Ge

2022
Curdlan, a Microbial β-Glucan, Has Contrasting Effects on Autoimmune and Viral Models of Multiple Sclerosis.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Animals; beta-Glucans; Disease Models, Animal; Mice; Multiple Sclerosis; Theilovirus

2022
Modulation of Microglia Polarization through Silencing of NF-κB p65 by Functionalized Curdlan Nanoparticle-Mediated RNAi.
    ACS applied materials & interfaces, 2020, Mar-11, Volume: 12, Issue:10

    Topics: Animals; beta-Glucans; Cell Physiological Phenomena; Cells, Cultured; Disease Models, Animal; Drug D

2020
STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis.
    Rheumatology (Oxford, England), 2021, 08-02, Volume: 60, Issue:8

    Topics: Adult; Animals; beta-Glucans; Cell Differentiation; Disease Models, Animal; Female; Humans; Ileitis;

2021
Dectin-1 Controls TSLP-Induced Th2 Response by Regulating STAT3, STAT6, and p50-RelB Activities in Dendritic Cells.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Adult; Allergens; Animals; Antigens, Dermatophagoides; Antigens, Plant; beta-Glucans; Case-Control S

2021
Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice.
    Arthritis & rheumatology (Hoboken, N.J.), 2014, Volume: 66, Issue:7

    Topics: Animals; Antibodies; beta-Glucans; Disease Models, Animal; Endoplasmic Reticulum Stress; Female; Ile

2014
Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.
    Cancer immunology research, 2014, Volume: 2, Issue:5

    Topics: Animals; beta-Glucans; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Line

2014
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice.
    Arthritis research & therapy, 2015, Aug-19, Volume: 17

    Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; beta-Glucans; Disease Models, Animal; Disea

2015
Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus Infections.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Animals; Aspergillus fumigatus; beta-Glucans; Cytokines; Disease Models, Animal; Epithelium, Corneal

2015
Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2011, Volume: 60, Issue:7

    Topics: Animals; Arthritis, Experimental; beta-Glucans; Cathepsins; Disease Models, Animal; Immunity, Innate

2011
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
    Journal of neurovirology, 2012, Volume: 18, Issue:6

    Topics: Adjuvants, Immunologic; Animals; beta-Glucans; Brain; Disease Models, Animal; Female; Genetic Vector

2012
Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines.
    The Journal of infectious diseases, 2013, Mar-15, Volume: 207, Issue:6

    Topics: Animals; Antibodies, Monoclonal; beta-Glucans; Disease Models, Animal; Immunologic Factors; Interfer

2013